Mike Solomon

Mike Solomon is the CEO at Ribometrix. Mike was previously self-employed as an independent biotechnology professional from January 2017 to February 2018. Prior to that, they were the Chief Operating Officer at Decibel Therapeutics from October 2015 to January 2017, and the Entrepreneur in Residence at Third Rock Ventures from March 2015 to January 2017. From December 2011 to March 2015, they were the Chief Operating Officer at Ember Therapeutics. From May 2009 to December 2011, they were the Chief Business and Technology Officer at Link Medicine. From June 2007 to May 2009, they were the Founder and VP of Discovery at Epizyme. And from May 2003 to May 2007, they were the VP of Research at Hypnion.

Mike Solomon has a PhD in Organic Chemistry from the University of Wisconsin-Madison, and a degree in Chemistry from the University of Massachusetts Amherst.

Barclay “Buck” Phillips - COO & CFO, John Reardon - Chief Scientific Officer, and Don Hertzog - VP, Drug Discovery report to Mike Solomon.